1. Home
  2. DDD vs TRML Comparison

DDD vs TRML Comparison

Compare DDD & TRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DDD
  • TRML
  • Stock Information
  • Founded
  • DDD 1986
  • TRML 2021
  • Country
  • DDD United States
  • TRML United States
  • Employees
  • DDD N/A
  • TRML N/A
  • Industry
  • DDD Computer peripheral equipment
  • TRML Biotechnology: Pharmaceutical Preparations
  • Sector
  • DDD Technology
  • TRML Health Care
  • Exchange
  • DDD Nasdaq
  • TRML Nasdaq
  • Market Cap
  • DDD 386.0M
  • TRML 419.1M
  • IPO Year
  • DDD N/A
  • TRML N/A
  • Fundamental
  • Price
  • DDD $3.22
  • TRML $22.72
  • Analyst Decision
  • DDD Buy
  • TRML Strong Buy
  • Analyst Count
  • DDD 3
  • TRML 3
  • Target Price
  • DDD $3.00
  • TRML $65.00
  • AVG Volume (30 Days)
  • DDD 2.4M
  • TRML 179.1K
  • Earning Date
  • DDD 12-03-2024
  • TRML 11-07-2024
  • Dividend Yield
  • DDD N/A
  • TRML N/A
  • EPS Growth
  • DDD N/A
  • TRML N/A
  • EPS
  • DDD N/A
  • TRML N/A
  • Revenue
  • DDD $454,796,000.00
  • TRML N/A
  • Revenue This Year
  • DDD N/A
  • TRML N/A
  • Revenue Next Year
  • DDD $5.45
  • TRML N/A
  • P/E Ratio
  • DDD N/A
  • TRML N/A
  • Revenue Growth
  • DDD N/A
  • TRML N/A
  • 52 Week Low
  • DDD $1.72
  • TRML $12.12
  • 52 Week High
  • DDD $6.85
  • TRML $48.31
  • Technical
  • Relative Strength Index (RSI)
  • DDD 52.79
  • TRML 35.49
  • Support Level
  • DDD $2.58
  • TRML $25.58
  • Resistance Level
  • DDD $3.10
  • TRML $27.51
  • Average True Range (ATR)
  • DDD 0.26
  • TRML 1.80
  • MACD
  • DDD -0.04
  • TRML -0.62
  • Stochastic Oscillator
  • DDD 52.46
  • TRML 2.12

About DDD 3D Systems Corporation

3D Systems Corp provides comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, on-demand manufacturing services, and digital design tools. The company's segments include Healthcare Solutions and Industrial Solutions. It generates maximum revenue from the Industrial segment. It conducts business through various offices and facilities located throughout the Americas, EMEA, and APAC; generating a vast majority of revenues from the Americas.

About TRML Tourmaline Bio Inc.

Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.

Share on Social Networks: